Ahmed F. Osman, MD

Dr. Ahmed F. Osman, MD, FACC, FASE, FESC, FHRS is a clinical Cardiac Electrophysiologist in practice in Broward County since December 2004. He is a founding member of the Florida Heart Rhythm Specialists, PLLC. He is the Medical Director of the EP Lab at Broward General Medical Center in Fort Lauderdale, Florida and is a Clinical Assistant Professor at the NOVA Southeastern University School of Medicine.

Dr. Osman graduated with honors from the Faculty of Medicine of the Cairo University, Kasr El Eini Hospital, Cairo, Egypt. He then completed his internal medicine training at the Norwalk Hospital/Yale University program in Connecticut. He received extensive training in the cardiovascular medicine program at The Ochsner Medical Foundation in New Orleans, Louisiana. His electrophysiology fellowship was completed at the University of Maryland Medical Center in Baltimore, Maryland, where he also served as assistant lecturer at the Department of Medicine.

Dr. Osman is board certified in internal medicine, cardiovascular medicine, clinical cardiac electrophysiology, nuclear cardiology and echocardiography. He is an active member and fellow in many professional societies including the American Colleges of Physicians (ACP) and Cardiology (ACC), Societies of Nuclear Cardiology (ASNC) and Echocardiography (ASE), Medical (AMA) and Heart Associations (AHA), Heart Rhythm Society (HRS) and European Society of Cardiology (ESC).

He has multiple peer reviewed publications in the fields of heart failure and non-invasive risk assessment for sudden death. He is an active clinical investigator in several multicenter studies assessing optimization of pacemaker and defibrillator therapy in patients with heart failure and at risk for sudden death.

Dr. Osman specializes in cardiac ablation for curative intervention on rhythm disturbances including atrial fibrillation and ventricular arrhythmias. He also offers all aspects of cardiac device therapies, from implantation of pacemakers and defibrillators, including “biventricular” therapies, to post-implant follow-up and optimization of programming. He has practicing privileges at most North Broward County hospitals.

• Fellow, European Society of Cardiology (ESC) 
• Member, European Heart Rhythm Association (EHRA)
• Fellow, American College of Cardiology (ACC) 
• Member, Clinical Council on Clinical Cardiology
• American Heart Association (AHA) 
• Member and Fellow, American Society of Echocardiography (ASE) 
• Member, American Society of Nuclear Cardiology (ASNC)

Awards:

• Best Doctor Award, Gulf Coast magazine 2011 yearly to present.  -Humanitarian award, Fort Lauderdale Caducean Society, 2018 
• Recipient of 1st Distinguished Physician Award, Broward Health Medical Center, 2015 
• Recipient of the Ochsner Foundation Award for excellence in medical writing, 99’
• The Samuel Floch award for 1995, Norwalk Hospital, Yale, best intern
• Medical school: Graduated: excellent with honors 12/91
• Pharmacology: 1st prize 1988, Cairo University, Faculty of medicine

Publications :

1. “Enhanced detection of arrhythmia vulnerability using T wave Alternans, Left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.” Eric J. Rashba, Ahmed F. Osman, Karen MacMurdy, Malcolm M. Kirk, Samantha E. Sarang, Robert W. Peters, Stephen R. Shorofsky and Michael R. Gold. J Cardiovascular Electrophysiology, Vol. 15, pp. 170-176, February 2004
2. “Body composition and prognosis in chronic systolic heart failure: the obesity paradox.” Lavie CJ, Osman AF, Milani RV, Mehra MR. Am J Cardiol. 2003 Apr 1; 91(7): 891-4
3. “Exercise is superior to pacing for T wave Alternans measurement in subjects with chronic coronary artery disease and left ventricular dysfunction”. Eric J. Rashba, MD, Ahmed F. Osman, MD, Karen MacMurdy, MD, Malcolm M. Kirk, MD, Samantha Sarang, RN, Robert W. Peters, MD, Stephen R. Shorofsky, MD, PhD, and Michael R. Gold, MD, PhD. J Cardiovasc Electrophysiol, Vol. 13, pp.845-850, September 2002
4. “Influence of QRS duration on the prognostic value of T wave Alternans.” Eric J. Rashba, MD, Ahmed F. Osman, MD, Karen MacMurdy, MD, Malcolm M. Kirk, MD, Samantha Sarang, RN, Robert W. Peters, MD, Stephen R. Shorofsky, MD, PhD, and Michael R. Gold, MD, PhD. J Cardiovasc Electrophysiol, Vol. 13, pp. 770-775, August 2002
5. “T Wave Alternans for Ventricular Arrhythmia Risk Stratification”. Ahmed F. Osman, MD and Michael R. Gold, MD. PhD. Curr Opin Cardiol 2002. 17: 1-5 
6. “The Incremental Prognostic Importance of Body Fat Adjusted Peak Oxygen Consumption in Chronic Heart Failure”. Ahmed F. Osman, MD, Mandeep R. Mehra, MD, FACC, Carl J. Lavie, MD, FACC, Eduardo Nunez, MD, Richard V. Milani, MD, FACC. JACC vol. 36, No. 7, Dec. 2000, 2126-31
7. “Clinical Use of Heart Rate Variability”. Ahmed F. Osman, MD, Review, Published in the Resident Report on NASPE 99, Sept. 1999, Vol. 4, No. 7, 27-32
8. “Dual Left Anterior Descending Coronary Artery: A Rare Coronary Anomaly”. Ahmed F. Osman, Qasem Shamaileh, Youssef Goussos, and Christopher J. White. J Interven Cardiol 2000; 13: 123-128
9. “Cardioversion and Defibrillation: Indications and Clinical Use”. Review article. Ahmed F. Osman, MD, Carl J. Lavie, MD and Freddy Abi-Samra, MD. The Clinics Atlas of Office Procedures (cardiovascular disease), Sept. 2000; 409-19
10. “Lack of Benefit of an Active Pectoral Pulse Generator on Atrial Defibrillation Thresholds”. Michael R. Gold, MD PhD, Stephen R. Shorofsky, MD, PhD, Rachida Bouhouch, MD, Robert A. Joy, MD, D. Scott Kirby, MD, Ahmed F. Osman, MD and Eric J. Rashba, MD. J Cardiovasc Electrophysiol, Vol. 13, pp. 332-335, April 2002
11. Therapeutic Hypothermia Still Effective in Prevention of Anoxic Encephalopathy following Extended Period of Pulselessness during Cardiac Arrest. Rivera NT, Bray N, Osman A, Kumar S and Vicuña R. J Clin Exp Res Cardiol 1: 101 
12. Rare infection of ICD lead with candida Albicans:case report and literature review. Nina T.Rivera, Natasha bray, Hong Wang, Kenneth Zelnick, Ahmed Osman, and Ricardo Vicuna. Therapeutic Advances in cardiovascular disease: 1-9, 2014 
13. Long-term clinical outcomes and prognostic indicators for focal impulse and rotor modulation guided ablation: a single-center observational study . Matthew Lozier, Ronald Pachon, John Lee, Alexandra Sanchez, Elie Donath, Ahmed Osman. journal of electrocardiology, volume 61, july–august 2020, pages 153-159
14. Percutaneous left atrial appendage closure among patients with diabetes (insights from a national database). Mohamed Hamed, Ramez Morcos, Ayman Elbadawi, Ahmed Osman, Hani Jneid, Wissam Khalife, Brijeshwar Maini, Houman Khalili. Am J Cardiology. Volume 202, 1 sept. 2023 pp 144-150.